
Join to view full profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Rubin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1970 - 1973
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1967 - 1968
Medical University of South CarolinaClass of 1967
Emory UniversityBA, 1959 - 1963
Certifications & Licensure
MN State Medical License 1970 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014
Publications & Presentations
PubMed
- 21 citationsAn International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C. Bible, Michael E. Menefee, Chia Chi Josh Lin, Michael Millward, William J. Maples
Thyroid. 2020-09-08 - 94 citationsSurvival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.Naiyarat Prasongsook, Aditi Kumar, Ashish V. Chintakuntlawar, Robert L. Foote, Jan L. Kasperbauer
The Journal of Clinical Endocrinology and Metabolism. 2017-12-01 - 100 citationsEarly and Late Outcomes of Surgical Treatment in Carcinoid Heart DiseaseHeidi M. Connolly, Hartzell V. Schaff, Martin D. Abel, Joseph Rubin, J. Wells Askew
Journal of the American College of Cardiology. 2015-11-17
Journal Articles
- Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersBible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kas..., J Oncol Pract, 5/1/2012
- Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical TrialAlberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J, Int J Gastrointest Cancer, 1/3/2008
- Phase II study of intratumoral gene transfer of Allovectin-7 (plasmid DNA encoding HLA-B7 complexed with cationic lipid) in HLA-B7 negative patients with metastatic me...Hersh EM, Stopeck AT, Unger EC, Warneke JA, Silver HK, Klasa R, Doroshow JH, Rubin J, Galanis E, Rhinehart JJ, Cancer Gene Ther, 1/1/2003
Books/Book Chapters
Abstracts/Posters
- Pilot study of tigatuzumab (cs-1008) in combination with folfiri in patients with metastatic colorectal cancer (crc).Kim G, Borad M, Pitot H, Rubin J, Greenberg J, McCroskery P, Beckman R, Grothey A, Ann Oncol, 9/1/2012
- Invited Commentary.Rubin J, Ann Thorac Surg, 1/1/2009
- Meta-analyses of randomized trials assessing the interest of postoperative adjuvant chemotherapy in gastric cancer.Sakamoto J, Paoletti X, Global Adv/Adj Stomach Tumor Research through International Collaboration (GASTRIC), J Clin Oncol, 5/20/2008
Press Mentions
Surviving a Pancreatic Neuroendocrine TumorApril 29th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









